deltatrials
Completed NA NCT00799565

Mitral Valve Prolapse (MVP) - France Study

Genetic Polymorphisms in Idiopathic Mitral Valve Prolapse :A French Prospective Study Using a Genome Wide Analysis

Sponsor: Centre National de Génotypage

Conditions Mitral Valve Prolapse
Interventions catch of blood
Updated 6 times since 2017 Last updated: Jul 13, 2011 Started: Dec 31, 2008 Primary completion: Jul 31, 2011 Completion: Jul 31, 2011

Listed as NCT00799565, this NA trial focuses on Mitral Valve Prolapse and remains completed. Sponsored by Centre National de Génotypage, it has been updated 6 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

6 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed NA

  2. Sep 2024 — Sep 2025 [monthly]

    Completed NA

  3. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  4. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  5. Jun 2018 — Jan 2021 [monthly]

    Completed NA

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Dec 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre National de Génotypage
  • French Cardiology Society
  • Institut National de la Santé Et de la Recherche Médicale, France
  • Leducq Foundation
Data source: French Cardiology Society

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Amiens, France, Bordeaux, France, Boulogne, France, Brest, France, Clermont-Ferrand, France, Créteil, France, Dijon, France, La Seyne-sur-Mer, France, Lille, France, Limoges, France and 11 more location s